Publication:
Hypersensitivity to etoposide in case of metastatic gestational choriocarcinoma

Simple item page
dc.contributor.authorLazović, Biljana (36647776000)
dc.contributor.authorMilenković, Vera (13006375400)
dc.contributor.authorCross D Signelić, Marina (56013943200)
dc.contributor.authorMazić, Sanja (6508115084)
dc.contributor.authorJeremic, Katarina (6701486495)
dc.contributor.authorHrgović, Zlatko (7003671220)
dc.date.accessioned2025-06-12T20:51:29Z
dc.date.available2025-06-12T20:51:29Z
dc.date.issued2013
dc.description.abstractEtoposide is commonly used in the treatment of a variety of neoplasms. Hypersensitivity reactions to etoposide are infrequently reported and include hypotension, hypertension, flushing, diaphoresis, chest discomfort, dyspnea, bronchospasm and loss of consciousness. We report the case of a 39-year-old woman who experienced acute bronchospasm, tachycardia, hypoxia and hypotension. The symptoms resolved within an hour after administration of intravenous fluids, methylprednisolone, diphenhydramine and oxygen. Subsequently, the patient was given etoposide phosphate without incident. © 2013 S. Karger AG, Basel.
dc.identifier.urihttps://doi.org/10.1159/000353627
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-84892943932&doi=10.1159%2f000353627&partnerID=40&md5=6324a9e08ae14d5ab36bff19ba090700
dc.identifier.urihttps://remedy.med.bg.ac.rs/handle/123456789/8964
dc.subjectAllergy
dc.subjectEtoposide
dc.subjectGynecological malignancy
dc.titleHypersensitivity to etoposide in case of metastatic gestational choriocarcinoma
dspace.entity.typePublication

Files

Collections

Publikacije / Publications